Bayne W, Place V, Theeuwes F, Rogers J D, Lee R B, Davies R O, Kwan K C
Clin Pharmacol Ther. 1982 Aug;32(2):270-6. doi: 10.1038/clpt.1982.158.
Two osmotically driven, controlled-release dosage forms of indomethacin were evaluated in a multiple-dose crossover study in 12 healthy subjects. Following equivalent daily doses, less frequent dosing of both controlled-release forms resulted in plasma concentration profiles that are more uniform than those following capsule regimens. After the first day, morning predose plasma levels wer significantly higher for the controlled-release treatments. Renal clearances were similar between days and among treatments. Total urinary recoveries were comparable for all regimens.
在一项针对12名健康受试者的多剂量交叉研究中,对两种渗透驱动的吲哚美辛控释剂型进行了评估。在每日剂量等效的情况下,两种控释剂型给药频率较低,其血浆浓度曲线比胶囊给药方案更均匀。第一天后,控释治疗组的晨起给药前血浆水平显著更高。各天之间以及各治疗组之间的肾脏清除率相似。所有给药方案的尿总回收率相当。